Download this datacard
Overview
Lobbying Costs
450,000€
Financial year: Jan 2014 - Dec 2014
Lobbyists (Full time equivalent)
0.75 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
2
Lobbying Costs over the years
-
Info
H. Lundbeck A/S (HLU)
EU Transparency Register
118500617129-29 First registered on 27 Apr 2015
Goals / Remit
H. Lundbeck A/S (LUN.CO, LUN DC, HLUKY) is an international pharmaceutical company highly committed to improve the quality of life for people suffering from disorders in the central nervous system (CNS). For this purpose Lundbeck is engaged in the research and development, production, marketing and sale of pharmaceuticals across the world, targeted at disorders like depression and anxiety, alcohol dependence, schizophrenia, insomnia, Huntington's, Alzheimer's and Parkinson's diseases.
Lundbeck was founded by Hans Lundbeck in 1915 in Copenhagen, Denmark, and today employs 5,900 people worldwide. Lundbeck is one of the world's leading pharmaceutical companies working with CNS disorders. In 2012, the company's revenue was DKK 14.8 billion. For more information, please visit www.lundbeck.com.Main EU files targeted
EAHF - EU Alcohol and Health Forum
Address
Head Office
Ottiliavej 9
Valby 2500
DENMARK -
People
Total lobbyists declared
2
Employment time Lobbyists 50% 1 25% 1 Lobbyists (Full time equivalent)
0.75
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Mr Anders Schroll (Vice President, Corporate Communication & Global Public Affairs)
Person with legal responsibility
Mr Håkan Björklund (Chairman with extended operational responsibilities)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Efpia - European Federation of Pharmaceutical Industries and Associations
http://www.efpia.eu/
DI - Confederation of Danish Industry
http://di.dk/English/Pages/English.aspx
EBC- European Brain Council
http://www.europeanbraincouncil.org/Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2014 - Dec 2014
Lobbying costs for closed financial year
450,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
Mental Health Interestgroup
Communication activities
None
Other activities
Legislation and public policy areas relevant for the pharmaceutical industry and Lundbeck's focus within central nervous system disorders, eg. mental health
Meetings
Meetings
2 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 12 Sep 2022 Location Copenhagen Subject Green and digital transition and Pharma strategy. Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Margrethe Vestager (Executive Vice-President)
- Christina Holm Eiberg (Cabinet member)
-
Date 21 May 2021 Location Copenhagen Subject Industrial Strategy Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Margrethe Vestager (Executive Vice-President)
Other Lobbyists